Clinical Perspectives and Pearls from the 2015 ESC NSTE-ACS Guidelines

被引:0
|
作者
Marco Roffi
Baris Gencer
Robert F. Storey
Felicita Andreotti
Carlo Patrono
机构
[1] Geneva University Hospitals,Division of Cardiology, Interventional Cardiology Unit
[2] University of Sheffield,Department of Infection, Immunity and Cardiovascular Disease
[3] Catholic University School of Medicine,Institute of Cardiology
[4] Catholic University School of Medicine,Institute of Pharmacology
来源
关键词
Guidelines; P2Y; inhibitors; Antiplatelet agents; Myocardial infarction; High-sensitivity cardiac troponins; Radial approach;
D O I
暂无
中图分类号
学科分类号
摘要
Four years after the latest edition, the 2015 non-ST-segment elevation acute coronary syndromes guidelines of the European Society of Cardiology have been published. Novel aspects include a new diagnostic algorithm for non-ST-segment elevation myocardial infarction using high-sensitivity cardiac troponins as well as guidance on cardiac rhythm monitoring duration. A large section is dedicated to antiplatelet therapy including initiation and duration of dual-antiplatelet therapy as well as the management of patients requiring, at the same time, long-term oral anticoagulation. New sections include the management of antiplatelet agent in patients requiring coronary artery bypass surgery and of acute bleeding events related to antiplatelet agents, vitamin K antagonist (VKA), and non-VKA oral anticoagulant drugs. Current evidence supports the radial access over the femoral one for coronary angiography and percutaneous revascularization.
引用
收藏
相关论文
共 50 条
  • [1] Clinical Perspectives and Pearls from the 2015 ESC NSTE-ACS Guidelines
    Roffi, Marco
    Gencer, Baris
    Storey, Robert F.
    Andreotti, Felicita
    Patrono, Carlo
    CURRENT CARDIOLOGY REPORTS, 2016, 18 (05)
  • [2] What is new in the 2020 ESC NSTE-ACS guidelines
    Roffi, Marco
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 (03)
  • [3] Management of Patients With NSTE-ACS A Comparison of the Recent AHA/ACC and ESC Guidelines
    Rodriguez, Fatima
    Mahaffey, Kenneth W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (03) : 313 - 321
  • [5] Early anticoagulation in the current management of NSTE-ACS: Evidence, guidelines, practice and perspectives
    Galli, Mattia
    Porto, Italo
    Andreotti, Felicita
    D'Amario, Domenico
    Vergallo, Rocco
    Della Bona, Roberta
    Crea, Filippo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 275 : 39 - 45
  • [6] Comments on the 2015 Guidelines of the European Society of Cardiology (ESC) for the Management of non-ST Elevation acute Coronary Syndrome (NSTE-ACS)
    Mehilli, J.
    Hamm, C. W.
    Landmesser, U.
    Massberg, S.
    KARDIOLOGE, 2016, 10 (06): : 351 - 358
  • [7] Clinical Shortcuts: Duration of dual Antiplatelet-therapy after Coronary Intervention (based on the Revascularization-Guidelines 2014 [1] and NSTE-ACS Guidelines 2015 [2] of the ESC)
    Alber, H.
    JOURNAL FUR KARDIOLOGIE, 2016, 23 (9-10): : 242 - 242
  • [8] Logistical consequences of 2015 ESC NSTE-ACS guideline implementation on patient flow of NSTE-ACS patients presenting at non-PCI centres in the Netherlands: a registry-based evaluation
    Hoedemaker, N. P. G.
    Damman, P.
    Bosker, H. A.
    Danse, P. W.
    Liem, A. H.
    Geerdes, B.
    Van Laarhoven, H.
    De Winter, R. J.
    EUROPEAN HEART JOURNAL, 2018, 39 : 353 - 353
  • [9] NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View
    Angoulvant, Denis
    Sabouret, Pierre
    Savage, Michael P.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (05) : 483 - 486
  • [10] NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View
    Denis Angoulvant
    Pierre Sabouret
    Michael P. Savage
    American Journal of Cardiovascular Drugs, 2021, 21 : 483 - 486